Association of IL-17, IL-21, and IL-23R gene polymorphisms with HBV infection in kidney transplant patients

Viral Immunology

Volumn 26, Issue 3, 2013, Pages 201-206

  Hejr, Sara ^a,b   Karimi, Mohammad Hossein ^a   Yaghobi, Ramin ^a   Kamali Sarvestani, Eskandar ^c,d   Geramizadeh, Bita ^a   Roozbeh, Jamshid ^e  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; GENOMIC DNA; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 23 RECEPTOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISOLONE; VIRUS DNA;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHILD; CONTROLLED STUDY; DRUG DOSE REDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS B VIRUS; HETEROZYGOTE; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE FREQUENCY; HEPATITIS B; HUMANS; INFANT; INTERLEUKIN-17; INTERLEUKINS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN; TRANSPLANTATION; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 84879136200     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2013.0007     Document Type: Article

References (34)

1. Arjmandi K, Yaghobi R, Ravanshad M, et al. Laboratory effect of HBV infection in kidney transplant recipients and donors. Transplant Proc 2011;43:554-556
2. Awasthi A, Riol-Blanco L, Jäger A, et al. Cutting edge: IL23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells. J Immunol 2009;182:5904-5908
3. Baan CC, Balk AH, Dijke IE, et al. Interleukin-21: An interleukin-2 dependent player in rejection processes. Transplantation 2007;83:1485-1492
4. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008;8:753-760
5. + T cells of peripheral blood from the different clinical types of patients infected with hepatitis B virus. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2011;27:304-306
6. Dubin PJ, Kolls JK. Th17 cytokines and mucosal immunity. Immunol Rev 2008;226:160-171
7. Franks I. Viral hepatitis: Interleukin 21 has a key role in agedependent response to HBV. Nat Rev Gastroenterol Hepatol 2011;8:243
8. Ge J, Wang K, Meng QH, et al. Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol 2010;30:60-67
9. Hecker A, Kaufmann A, Hecker M, et al. Expression of interleukin-21, interleukin-21 receptor alpha and related type I cytokines by intravascular graft leukocytes during acute renal allograft rejection. Immunobiology 2009;214:41-49
10. Hu X, Ma S, Huang X, et al. Interleukin-21 is upregulated in hepatitis B-related acute-on-chronic liver failure and associated with severity of liver disease. J Viral Hepat 2011;18:458-467
11. Huang Z, van Velkinburgh JC, et al. Pivotal roles of the interleukin-23/T helper 17 cell axis in hepatitis B. Liver Int 2012;32:894-901
12. Hue S, Ahern P, Buonocore S, et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med 2006;203:2473-2483
13. Infante-Duarte C, Horton HF, Byrne MC, Kamradt T. Microbial lipopeptides induce the production of IL-17 in Th cells. J Immunol 2000;165:6107-6115
14. Koyama S, Ishii KJ, Coban C, et al. Innate immune response to viral infection. Cytokine 2008;43:336-341
15. Lafdil F, Miller AM, Ki SH, et al. Th17 cells and their associated cytokines in liver diseases. Cell Mol Immunol 2010;7:250-254
16. Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005;201:233-240
17. Lupardus PJ, Garcia KC. The structure of interleukin-23 reveals the molecular basis of p40 subunit sharing with interleukin-12. J Mol Biol 2008;382:931-941
18. Ma SW, Huang X, Li YY, et al. High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B. J Hepatol 2012;56:775-781
19. Maini MK, Boni C, Lee CK, et al. The role of virus-specific CD8 (+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 2000;191: 1269-1280
20. Niu Y, Liu H, Yin D, et al. The balance between intrahepatic IL-17 (+) T cells and Foxp3 (+) regulatory T cells plays an important role in HBV-related end-stage liver disease. BMC Immunol 2011;19:12-47
21. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005;6:1133-1141
22. Phillips S, Chokshi S, Riva A, et al. CD8 (+) T cell control of hepatitis B virus replication: Direct comparison between cytolytic andnoncytolytic functions. J Immunol 2010;184: 287-295
23. Publicover J, Goodsell A, Nishimura S, et al. IL-21 is pivotal in determining age-Dependent effectiveness of immune responses in a mouse model of human hepatitis B. J Clin Invest 2011;121:1154-1162
24. Rehermann B. Intrahepatic T cells in hepatitis B: Viral control versus liver cell injury. J Exp Med 2000;191:1263-1268
25. Riol-Blanco L, Lazarevic V, Awasthi A, et al. IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infections. J Immunol 2010;184:1710-1720
26. Tsai JP, Yang SF, Wu SW, et al. Association between interleukin 23 receptor polymorphism and kidney transplant outcomes: A 10-year Taiwan cohort study. Clin Chim Acta 2011;412:958-962
27. Wang L, Chen S, Xu K. IL-17 expression is correlated with hepatitis B-related liver diseases and fibrosis. Int J Mol Med 2011;27:385-392
28. Wang Q, Zheng Y, Huang Z, et al. Activated IL-23/IL-17 pathway closely correlates with increased Foxp3 expression in livers of chronic hepatitis B patients. BMC Immunol 2011;14:12-25
29. Wu W, Li J, Chen F, et al. Circulating Th17 cells frequency is associated with the disease progression in HBV infected patients. J Gastroenterol Hepatol 2010;25:750-757
30. Xu Y, DU WJ, Qin LY, et al. Expression of interleukin-17 in hepatitis B related liver fibrosis. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2009;25:133-135
31. Ye Y, Xie X, Yu J, et al. Involvement of Th17 and Th1 effector responses in patients with hepatitis B. J Clin Immunol 2010;30:546-555
32. Zhang F, Yao S, Yuan J, et al. Elevated IL-6 receptor expression on CD4 + T cells contributes to the increased Th17 responses in patients with chronic hepatitis B. Virol J 2011;3:270-280
33. Zhang JY, Song CH, Shi F, et al. Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatment. PLoS One 2010;5:13869
34. + T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 2010;51: 81-91